{"title":"SARC-F 问卷各项目对泌尿系统癌症大手术患者预后的影响","authors":"Kohei Hirose, Shugo Yajima, Ryo Andy Ogasawara, Naoki Imasato, Sao Katsumura, Madoka Kataoka, Yasukazu Nakanishi, Hitoshi Masuda","doi":"10.22540/JFSF-09-201","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to evaluate the association between scores on each item of the SARC-F questionnaire and life expectancy in patients undergoing major surgery for urologic cancer.</p><p><strong>Methods: </strong>This retrospective study included 1018 patients undergoing elective major urologic cancer surgery. All patients completed the SARC-F questionnaire preoperatively. Demographic and clinical data were collected. The primary endpoint was an association between SARC-F scores and overall survival (OS).</p><p><strong>Results: </strong>Of the 1018 patients, the median age was 72 years and 920 (90%) were male. Multivariate analysis revealed four factors significantly and independently associated with shorter OS: assistance with walking score ≥1 (Hazard ratio: HR=2.18, <i>P</i>=0.044), cancer stages ≥ III (HR=7.98, <i>P</i><0.001), high blood loss ≥78 ml or blood transfusion during surgery (HR=4.53, <i>P</i>=0.007 and HR=2.41, <i>P</i>=0.037, respectively).</p><p><strong>Conclusions: </strong>This study found that among the items of the SARC-F questionnaire, assistance with walking was a strong predictor of life expectancy. Incorporating such a simple screening tool into the preoperative assessment would help to ensure more appropriate perioperative care for urologic cancer patients.</p>","PeriodicalId":73754,"journal":{"name":"Journal of frailty, sarcopenia and falls","volume":"9 3","pages":"201-206"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367079/pdf/","citationCount":"0","resultStr":"{\"title\":\"Prognostic Impact of Each Item of the SARC-F Questionnaire in Patients Undergoing Major Surgery for Urologic Cancer.\",\"authors\":\"Kohei Hirose, Shugo Yajima, Ryo Andy Ogasawara, Naoki Imasato, Sao Katsumura, Madoka Kataoka, Yasukazu Nakanishi, Hitoshi Masuda\",\"doi\":\"10.22540/JFSF-09-201\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>We aimed to evaluate the association between scores on each item of the SARC-F questionnaire and life expectancy in patients undergoing major surgery for urologic cancer.</p><p><strong>Methods: </strong>This retrospective study included 1018 patients undergoing elective major urologic cancer surgery. All patients completed the SARC-F questionnaire preoperatively. Demographic and clinical data were collected. The primary endpoint was an association between SARC-F scores and overall survival (OS).</p><p><strong>Results: </strong>Of the 1018 patients, the median age was 72 years and 920 (90%) were male. Multivariate analysis revealed four factors significantly and independently associated with shorter OS: assistance with walking score ≥1 (Hazard ratio: HR=2.18, <i>P</i>=0.044), cancer stages ≥ III (HR=7.98, <i>P</i><0.001), high blood loss ≥78 ml or blood transfusion during surgery (HR=4.53, <i>P</i>=0.007 and HR=2.41, <i>P</i>=0.037, respectively).</p><p><strong>Conclusions: </strong>This study found that among the items of the SARC-F questionnaire, assistance with walking was a strong predictor of life expectancy. Incorporating such a simple screening tool into the preoperative assessment would help to ensure more appropriate perioperative care for urologic cancer patients.</p>\",\"PeriodicalId\":73754,\"journal\":{\"name\":\"Journal of frailty, sarcopenia and falls\",\"volume\":\"9 3\",\"pages\":\"201-206\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11367079/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of frailty, sarcopenia and falls\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.22540/JFSF-09-201\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of frailty, sarcopenia and falls","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22540/JFSF-09-201","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Prognostic Impact of Each Item of the SARC-F Questionnaire in Patients Undergoing Major Surgery for Urologic Cancer.
Objectives: We aimed to evaluate the association between scores on each item of the SARC-F questionnaire and life expectancy in patients undergoing major surgery for urologic cancer.
Methods: This retrospective study included 1018 patients undergoing elective major urologic cancer surgery. All patients completed the SARC-F questionnaire preoperatively. Demographic and clinical data were collected. The primary endpoint was an association between SARC-F scores and overall survival (OS).
Results: Of the 1018 patients, the median age was 72 years and 920 (90%) were male. Multivariate analysis revealed four factors significantly and independently associated with shorter OS: assistance with walking score ≥1 (Hazard ratio: HR=2.18, P=0.044), cancer stages ≥ III (HR=7.98, P<0.001), high blood loss ≥78 ml or blood transfusion during surgery (HR=4.53, P=0.007 and HR=2.41, P=0.037, respectively).
Conclusions: This study found that among the items of the SARC-F questionnaire, assistance with walking was a strong predictor of life expectancy. Incorporating such a simple screening tool into the preoperative assessment would help to ensure more appropriate perioperative care for urologic cancer patients.